A Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) in Healthy Children, Adults, and Elderly

Human Vaccines and Immunotherapeutics - United States
doi 10.1080/21645515.2018.1509648
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Immunogenicity and Tolerance of a 7-Valent Pneumococcal Conjugate Vaccine in Nonresponders to the 23-Valent Pneumococcal Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2000English

PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or No Vaccination (NoVac) in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Efficacy and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Rheumatoid Arthritis

The Clinician
2015English

Safety and Immunogenicity of 15-Valent Pneumococcal Conjugate Vaccine (PCV-15) Compared to PCV-13 in Healthy Older Adults

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Pin43 - A Cost-Effectiveness Analysis of Revaccinating Older Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared to Vaccinating With a Single Dose of Ppv23 in the United Kingdom (Uk)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Immunogenicity and Safety of 7-Valent Pneumococcal-Crm197 Conjugate Vaccine. ▴ 1082

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

MMWR. Morbidity and mortality weekly report
Health Information ManagementMutagenesisEpidemiologyHealthMedicineToxicology
2019English

The Use of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients With Rheumatoid Arthritis

Epidemiology and Vaccine Prevention
2015English

Assessment of Clinical and Immunological Efficacy and Safety of 23-Valent Pneumococcal Vaccine in Patients With Rheumatoid Arthritis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy